Identifying modulators of hERG channel activity using the PatchXpress® planar patch clamp

被引:69
作者
Dubin, AE
Nasser, N
Rohrbacher, J
Hermans, AN
Marrannes, R
Grantham, C
Van Rossem, K
Cik, M
Chaplan, SR
Gallacher, D
Xu, J
Guia, A
Byrne, NG
Mathes, C
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Pain Related Disorders, San Diego, CA 92121 USA
[2] Johnson & Johnson Pharmaceut Res & Dev, Ctr Excellence Cardiovasc Safety Res, Beerse, Belgium
[3] Johnson & Johnson Pharmaceut Res & Dev, CNS Pain & Alzheimer, Beerse, Belgium
[4] Johnson & Johnson Pharmaceut Res & Dev, Psychiat 1, Beerse, Belgium
[5] Johnson & Johnson Pharmaceut Res & Dev, Assay Dev & High Throughput Screening, Beerse, Belgium
[6] AVIV Biosci Corp, San Diego, CA USA
[7] Mol Devices Corp, Union CIty, CA USA
关键词
voltage clamp; automation; throughput; assay; human ether-a-go-go related gene potassium channel;
D O I
10.1177/1087057104272295
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The authors used the PatchXpress((R)) 7000A system to measure compound activity at the hERG channel using procedures that mimicked the "gold-standard" conventional whole-cell patch clamp. A set of 70 compounds, including hERG antagonists with potencies spanning 3 orders of magnitude, were tested on hERG302-HEK cells using protocols aimed at either identifying compound activity at a single concentration or obtaining compound potency from a cumulative concentration dependence paradigm. After exposure to compounds and subsequent washout of the wells to determine reversibility of the block, blockade by a reference compound served as a quality control. Electrical parameters and voltage dependence were similar to those obtained using a conventional whole-cell patch clamp. Rank order of compound potency was also comparable to that determined by conventional methods. One exception was flunarizine, a particularly lipophilic compound. The PatchXpress((R)) accurately identified the activity of 29 moderately potent antagonists, which only weakly displace radiolabeled astemizole and are false negatives in the binding assay. Finally, no false hits were observed from a collection of relatively inactive compounds. High-quality data acquisition by PatchXpress((R)) should help accelerate secondary screening for ion channel modulators and the drug discovery process.
引用
收藏
页码:168 / 181
页数:14
相关论文
共 23 条
[1]   HERG K+ channel activity is regulated by changes in phosphatidyl inositol 4,5-bisphosphate [J].
Bian, JS ;
Cui, J ;
McDonald, TV .
CIRCULATION RESEARCH, 2001, 89 (12) :1168-1176
[2]  
Brueggemann A, 2004, Curr Drug Discov Technol, V1, P91, DOI 10.2174/1570163043484833
[3]  
Chouabe C, 1998, MOL PHARMACOL, V54, P695
[4]  
De Ponti F, 2002, DRUG SAFETY, V25, P263
[5]   The pharmacological and functional characteristics of the serotonin 5-HT3A receptor are specifically modified by a 5-MT3B receptor subunit [J].
Dubin, AE ;
Huvar, R ;
D'Andrea, MR ;
Pyati, J ;
Zhu, JY ;
Joy, KC ;
Wilson, SJ ;
Galindo, JE ;
Glass, CA ;
Luo, L ;
Jackson, MR ;
Lovenberg, TW ;
Erlander, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30799-30810
[6]  
DUBIN AE, 2004, DRUG DISC ION CHANN
[7]   IMPROVED PATCH-CLAMP TECHNIQUES FOR HIGH-RESOLUTION CURRENT RECORDING FROM CELLS AND CELL-FREE MEMBRANE PATCHES [J].
HAMILL, OP ;
MARTY, A ;
NEHER, E ;
SAKMANN, B ;
SIGWORTH, FJ .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1981, 391 (02) :85-100
[8]   High throughput ion-channel pharmacology: Planar-array-based voltage clamp [J].
Kiss, L ;
Bennett, PB ;
Uebele, VN ;
Koblan, KS ;
Kane, SA ;
Neagle, B ;
Schroeder, K .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (01) :127-135
[9]   Computer programs to facilitate the estimation of time-dependent drug effects on ion channels [J].
Marrannes, R ;
De Prins, E .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2004, 74 (02) :167-181
[10]  
MARTY A, 1985, SINGLE CHANNEL RECOR, P115